Gamida Cell Ltd. - Ordinary Shares (GMDA) Social Stream
GAMIDA CELL LTD (GMDA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering GAMIDA CELL LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 4 | $27 | $11 | $18.4 | $0.295 | 6137.29% |
| 2021-11-16 | 5 | $22 | $11 | $15 | $0.295 | 4984.75% |
| 2022-03-24 | 5 | $22 | $11 | $14.6 | $0.295 | 4849.15% |
| 2022-04-26 | 6 | $22 | $11 | $14.6 | $0.295 | 4849.15% |
| 2022-08-02 | 6 | $22 | $6 | $13.2 | $0.295 | 4374.58% |
| 2022-08-16 | 5 | $22 | $6 | $13.2 | $0.295 | 4374.58% |
| 2022-09-12 | 5 | $22 | $8 | $13.6 | $0.295 | 4510.17% |
| 2022-09-30 | 5 | $22 | $8 | $13 | $0.295 | 4306.78% |
| 2022-10-02 | 5 | $22 | $7 | $12.8 | $0.295 | 4238.98% |
| 2022-11-15 | 5 | $22 | $7 | $13.25 | $0.295 | 4391.53% |
| 2022-11-22 | 5 | $22 | $7 | $12 | $0.295 | 3967.8% |
| 2023-02-21 | 5 | $22 | $7 | $11.75 | $0.295 | 3883.05% |
| 2023-04-18 | 5 | $8 | $5 | $6.5 | $0.295 | 2103.39% |
| 2023-04-20 | 5 | $11 | $5 | $7.5 | $0.295 | 2442.37% |
| 2023-05-15 | 4 | $11 | $5 | $7.5 | $0.295 | 2442.37% |
| 2023-05-16 | 5 | $11 | $5 | $7 | $0.295 | 2272.88% |
| 2023-05-22 | 5 | $11 | $5 | $6.8 | $0.295 | 2205.08% |
| 2023-08-16 | 4 | $11 | $5 | $7 | $0.295 | 2272.88% |
| 2023-11-15 | 4 | $6 | $2 | $4.75 | $0.295 | 1510.17% |
The Trend in the Analyst Price Target
GMDA's average price target has moved down $9.85 over the prior 22 months.
Over the past 38 weeks, GMDA's average upside potential has been 440.14%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-21 | 4 | 22 | 7 | 11.75 | 1.450 | 710.34% |
| 2023-04-20 | 4 | 11 | 5 | 7.50 | 1.655 | 353.17% |
| 2023-05-16 | 5 | 11 | 5 | 7.00 | 2.030 | 244.83% |
| 2023-05-22 | 5 | 11 | 5 | 6.80 | 1.950 | 248.72% |
| 2023-08-16 | 4 | 11 | 5 | 7.00 | 1.240 | 464.52% |
GMDA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 3 | 1 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 43 months, GMDA's average broker recommendation rating worsened by 0.25.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, GAMIDA CELL LTD's upside potential (average analyst target price relative to current price) is higher than 1986.92% of them.
- In the context of all US stocks, GAMIDA CELL LTD's average analyst price target is higher than 253.92% of them.
- In the context of stocks in the small market cap category, GAMIDA CELL LTD's variance in analysts' estimates is lower than -1521.22% of them.
- GMDA has a greater number of analysts covering the stock than 477.52% of Healthcare stocks.
Stocks similar to GAMIDA CELL LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IMTX, GRTS, and STRO.
View All Top Stocks by Price Target
Is GMDA a Buy, Hold or Sell? See the POWR Ratings now!